• Users Online: 20
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia
Manu Chaudhary,Shiekh G. Ayub,Mohd A. Mir
Journal of Infection and Public Health.2018;11(5)691
[DOI]
2Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia
Shih-Lung Cheng,Ren-Guang Wu,Yin-Ching Chuang,Wann-Cherng Perng,Shih-Ming Tsao,Yu-Ting Chang,Li-Wen Chang,Ming-Chu Hsu
Journal of Microbiology, Immunology and Infection.2019;52(5)743
[DOI]
3Identification of hospitalized patients with community-acquired infection in whom treatment guidelines do not apply: a validated model
Teresa Cardoso,Pedro Pereira Rodrigues,Cristina Nunes,Mónica Almeida,Joana Cancela,Fernando Rosa,Nuno Rocha-Pereira,Inês Ferreira,Filipa Seabra-Pereira,Prudência Vaz,Liliana Carneiro,Carina Andrade,Justin Davis,Ana Marçal,N Deborah Friedman
Journal of Antimicrobial Chemotherapy.2019;52(5)743
[DOI]
Feedback

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal